Ab&b Bio-tech Co., Ltd.js

This study tested a new 23-valent pneumococcal polysaccharide vaccine in 144 healthy people aged 2 and older. Participants received one dose of either the experimental or a control vaccine. The main goal was to check safety and how well the vaccine triggers an immune response.

This study tested the safety of a new rabies vaccine in 80 healthy people aged 10 to 60. Participants received the vaccine using one of two different schedules (Essen or Zagreb). The researchers monitored for side effects for up to 6 months. The goal was to see if the vaccine is …